Can the dual-functional capability of CIK cells be used to improve antitumor effects?
Authors:
- 1 January 2014
- journal article
- review article
- Published by Elsevier in Cellular Immunology
- Vol. 287 (1) , 18-22
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancerCancer Immunology, Immunotherapy, 2012
- Combination Strategies to Enhance Antitumor ADCCImmunotherapy, 2012
- Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicityBlood, 2011
- Innate or Adaptive Immunity? The Example of Natural Killer CellsScience, 2011
- Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)Journal of Cancer Research and Clinical Oncology, 2010
- Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cellsImmunological Reviews, 2009
- Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15Journal of Experimental Medicine, 2009
- Characterization of the recognition and functional heterogeneity exhibited by cytokine‐induced killer cell subsets against acute myeloid leukaemia target cellImmunology, 2009
- The mechanisms of action of rituximab in the elimination of tumor cellsSeminars in Oncology, 2003
- Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated CytolysisAnnual Review of Immunology, 2001